We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BioResearch

Image: Aura ESD ductless fume hoods are self-contained, filtered enclosures that remove hazardous fumes, vapors and particles from virtually any laboratory application. Unlike traditional fume hoods, there are no installation costs and no ductwork is needed (Photo courtesy of Mystaire Misonix).

Electrostatic Dissipative Feature Augments New Line of Ductless Fume Hoods

A new line of fume hoods that promises laboratory workers superior protection against buildup of toxic fumes has been combined with electrostatic dissipative features to prevent static buildup and discharge. More...
13 Aug 2013

Research Agreement to Promote Development of Monoclonal Antibody-based Therapeutics

A consortium of biotech companies will promote the use of modified recombinant antibodies for use in the development of monoclonal antibody-based therapeutics to fight cancer and other life-threatening and debilitating diseases. More...
13 Aug 2013
Image: Yale University researchers have developed an ultracompact, low-cost spectrometer with improved resolution over existing micro models. The innovation represents an advance in “lab-on-a-chip” technology, or the consolidation of laboratory capabilities in miniature, highly portable devices (Photo courtesy of Yale University).

Prototype Microspectrometer Suitable for Lab-on-a-Chip Technologies

By passing a beam of light through a silicon chip pierced with randomly scattered holes investigators have developed a sensitive microspectrometer that may be adaptable for "lab-on-a-chip" applications. More...
12 Aug 2013
Image: Investigators at The Scripps Research Institute have achieved the first efficient chemical synthesis of ingenol, a highly complex, anticancer substance found in the Euphorbia genus of plant, whose milky sap has long been used in traditional medicine (Photo courtesy of the Scripps Research Institute).

Drug Development Cooperation Yields Synthetic Route for Anti-Skin Cancer Compounds

Cooperation between a Danish pharmaceutical company and a renowned American research institute has resulted in development of a method for chemical synthesis of the anticancer drug ingenol, which up to now could only be inefficiently extracted from plant materials. More...
12 Aug 2013
Image: Researchers from Missouri University of Science and Technology have developed a type of glass implant that could one day be used to repair injured bones in the arms, legs and other areas of the body that are most subject to the stresses of weight (Photo courtesy of Missouri University of Science and Technology).

Glass Scaffolds Designed to Repair Bones Also Show Potential as Weight-Bearing Implants

Researchers have developed a type of glass implant that could soon be used to heal damaged bones in the legs, arms, and other areas of the body that are most exposed to the weight-bearing stresses. More...
08 Aug 2013
Image: This diagram shows the process by which scientists can take skin cells from patients with epilepsy, convert them to stem cells, and then create neurons (brain nerve cells) from them. The induced neurons contain the same genetic mutation(s) carried by the patients (Photo courtesy of the University of Michigan Medical School).

Neurons Derived from the Skin Cells of Epilepsy Patients Embody New Platform for Drug Testing

Stem cells derived from skin taken from juvenile epilepsy patients were induced to mature into cultures of neurons that were developed into a human-based system for the study of the genetic factors that underlie the disorder and for development of drugs to control the disease. More...
08 Aug 2013
Image: Cross section of a potassium channel in a smooth muscle cell of the pulmonary artery. A recent study has identified six new mutations in a gene called KCNK3 that can interfere with the function of potassium channels and lead to pulmonary hypertension. The mutations are depicted in color at the locations where they exert their effects (Photo courtesy of Columbia University Medical Center).

Mutation in Potassium Channel Gene Linked to Rare Form of Pulmonary Hypertension

A mutation in a gene that encodes a potassium channel protein has been linked to development of the rare disease idiopathic pulmonary arterial hypertension. More...
08 Aug 2013
Visit expo >
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Manual Pipetting Aid
Pipette Controllers macro
Electrolyte Analyzer
BKE-B

In Other News



BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.